Ann: Joint Venture for Anti-Viral and Anti-Bacterial Face Masks, page-21

Capacity of 5 Million masks per/month or 60M per/year, with potential to increase.

Of note: One of the largest mask manufacturers of N95 masks in the world is 3M.

3M's total worldwide production of N95 masks (in billion units):
- 2019 0.63B
- 2020 2B
- 2021 (will be) 2.5B

https://www.statista.com/statistics/1232566/global-n95-mask-production-of-3m/




The product could become the new industry standard; being used in the medical field, hospitality and by all face to face workers.

Australia could easily absorb the 60 million mask units within our own country,

Prices above are in $US, but the price demands a higher pricing point because:
- It is a Covid killing mask
- It is reusable

The licensing is not included and this would have MUCH greater potential with Australia having a very small population, and there being a global market network. Licensing falls directly within the PPK modelling structure.




All these numbers represent a nice addition to the PPK stable.

On a different level, how can you put a number on the market reach of this product? Placing products in businesses worldwide and increasing product awareness for other Joint Ventures under the PPK umbrella. What would this cost in advertising - it is effectively "free advertising".

And the "free advertising" has a higher $Value than the product itself.

IMO DYOR